Arlington Capital Partners, a Washington, DC-based private equity firm, has completed a majority growth investment in Riverpoint Medical, a developer, designer, and manufacturer of medical devices focused on advanced bio-medical textile technologies. Riverpoint's founders and senior management have all made substantial investments as part of the transaction and will continue to lead the company's strategic growth initiatives in the future. Matt Altman, a Managing Partner at Arlington, says: "Riverpoint's ability to develop innovative technologies coupled with its unique manufacturing processes provide a strong platform to accelerate growth in large addressable markets. Our investment in Riverpoint continues Arlington's history of building differentiated, high-growth medical device manufacturers in partnership with company founders and existing senior management."